surmount-1 trial tirzepatide weight loss nondiabetic Delivers in SURMOUNT-2 🔴Tirzepatide for obesity and diabetes

Personalized Health Insights : The test results provide detailed reports on your genetic predispositions and how they may influence your wellness

consulting fees from Eli Lilly, Novo Nordisk, Medison, and Rhythm Pharmaceuticals

If you are pregnant or plan to become pregnant, you should not use tirzepatide

The triple comparison with retatrutide adds the next-generation option to the evaluation

Key Points Tirzepatide leads to an average of 15-21% weight loss in clinical trials In general, higher doses produce greater weight loss results Tirzepatide treatment typically begins with a 2.5 mg starter dose with a gradual increase to maintenance doses of 10-15 mg Weight loss on tirzepatide is linked to a balanced diet and regular physical activity Tirzepatide has been shown to deliver impressive weight loss results

A patient with severe insulin resistance may benefit from staying at 10 mg longer to maximize metabolic improvement, while another person might reach satiety goals at 5 mg and experience diminishing returns at higher doses